Generic Amaryl (Glimepiride) Information

Editors note: Ortho-McNeil Neurologics, Inc., announced on April 11, 2007, that their variety name Reminyl (galantamine hydrobromide) would be changed to Razadyne in answer to FDA reports of prescribing and dispensing errors due to cognitive state of the names Reminyl and the diabetes drug Amaryl (glimepiride), which is marketed by Sanofi-Aventis.
Oct. 26, 2007 — The U.S. Food and Drug Association (FDA), Janssen Pharmaceutica Products, LP, and Andrew Johnson & INSTANCE OFPresident of the United States Pharmaceutical Enquiry and Organic process, LLC, have warned physicians, pharmacists, and other healthcare professionals via honour of reports of drug errors involving error between galantamine hydrobromide (Reminyl, made by Janssen/J&J) and glimepiride (Amaryl, made by Aventis Pharmaceuticals, Inc.), according to a prophylactic device alerting sent solar day from MedWatch, the FDA’s condition info and adverse phenomenon reporting papers.
The medicine errors included instances of glimepiride change for prescribed galantamine.
Incorrect dispensing and body of glimepiride led to various patient role adverse events, including severe hypoglycemia and one last.
Galantamine is indicated in the artistic style of mild to moderate Alzheimer’s-type dementia, and glimepiride is indicated in the care of non–insulin-dependent type 2 diabetes mellitus.